Company Description
Mikart’s 45+ years of experience in oral solid and nonsterile oral liquid dosage forms and specialization in pediatric, geriatric, and controlled substances make us the ideal contract development and manufacturing organization partner—from formulation development through commercialization. We value long-lasting relationships and a personalized approach, bringing both the reliability and flexibility to meet your needs and exceed your expectations.
For a solid foundation and flexible solutions to bring your product to life, choose Mikart.
Company Background
At Mikart, our mission is to leverage our technical expertise in pharmaceutical development and manufacturing to deliver services that meet the diverse needs of our customers. We foster a culture of empowerment, growth, and collaboration amongst our team members to ensure we expedite our customer’s development projects. Our goal is to be your preferred CDMO partner, driving the advancement of healthcare through reliable and efficient production of high-quality pharmaceutical products.
Mikart offers a comprehensive suite of services across the drug development and commercialization continuum. Wherever you are in the journey from conceptualization to maximizing market adoption, Mikart is your seasoned industry partner — we’ve been delivering the highest quality products surpassing the most exacting client standards for over 45 years.
Our emphasis on building long-lasting relationships and a collaborative, adaptable approach inform the flexible solutions we develop to meet your needs and exceed your expectations. Transparency,
reliability, and responsiveness are hallmarks of the Mikart experience, and form the foundation for expert, flexible solutions that advance your product.
Trust our proven expertise in oral solid and non-sterile oral liquid dosage forms — specializing in pediatrics, geriatrics, and controlled substances — from formulation through full-scale commercialization.
- CEO: Michael Kallelis
- CFO: Scott Neola
- VP, Product Development Services: Nazar Elkarim, PhD
- VP, Business Development: Louis Weber
- VP, Marketing: Michelle Hall
- VP, Quality: Andy Stribling
- VP, Manufacturing: Tom Head
- Supply Chain Director: Luisa Robertson
- Director of Formulation Development: Gus LaBella
Facilities
Mikart’s facilities, designed for the highest quality standards and maximum efficiency, go beyond FDA and cGMP standards. Throughout our 234,000 sq. ft. Atlanta facilities, all production rooms are designed with independent HEPA filtered HVAC systems monitored by a Kaye LabWatch network. Our low humidity suite is custom-designed to manufacture products requiring levels below 30% RH.
From the smallest iterative batch to the largest commercial production run, Mikart is your full-service production partner.
Services and Capabilities
Pre-Formulation, Formulation Development, Analytical method development, Pharmaceutical Regulatory Support, Small-Scale non-GMP Lab, Pharmaceutical Manufacturing Controlled Substances (CI-CV) Manufacturing
Clinical Trial Supplies, Dosage Forms: Liquids and Suspensions, Capsules, Tablets, Powder in a Bottle
Packaging Services: Blister/Carded Blisters Pouch/Foil Strip Packs, Cartoning/Tray Packaging, Unit Dose Cups, Bottle Filling Sachet Filling